Clarus Ventures

2005

Founded

87

Investments

United States

Offices

Venture Fund

Investor Type

About

Clarus Ventures is a life sciences venture capital firm founded in 2005 by a team of accomplished investment professionals with extensive and complementary industry backgrounds. The firm is dedicated to investing in the healthcare sector, managing over $1.7 billion across multiple funds. Clarus Ventures employs a hands-on investment philosophy, focusing on therapeutics-focused companies at all stages, with breakthrough science and/or best-in-class assets, and R&D -sharing partnerships with the pharmaceutical and biotech industry.

The team has been together for 15 years and has led over 120 healthcare investments, developing new medicines for important unmet medical needs. Clarus Ventures has offices in Cambridge, MA, and South San Francisco, CA.

Portfolio Companies

Gritstone Bio, Avrobio, Eyetech Pharmaceuticals, IntraTherapeutics, CryoCor, Hemosense, SFJ Pharmaceuticals, InControl, Quintiles Pharmaceuticals, Boston Scientific

Gepgraphic Focus

United States

Key Differentiators

Hands-on investment philosophy, Deep scientific and clinical development expertise, Extensive partnerships with entrepreneurs, the biopharmaceutical industry, and co-investors

Thypical Investment Size

$15 million to $50 million per investment

Total Funds Raised

$1.7 billion

Visit Website

Software

SaaS

Consumer

FinTech

Cambridge

Pre-Seed

Seed

Series A

Series B

Series C

Series D

United States